The Trump administration has extended the duration of a pilot programme to provide access to obesity drugs through Medicare, ...

In the pharmaceutical and healthcare sectors, where precision is paramount and human lives are directly impacted, these ...

A combination regimen for kidney cancer treatment based on MSD's Welireg has failed a phase 3 trial, denting the company's ...

After years of constrained capital markets, biotech companies are operating in an environment where even late-stage ...

Preeclampsia is a serious pregnancy disorder, affecting nearly 10 millionwomen globally each year, and can strike without ...

Novo Nordisk acquired rights to etavopivat when it bought Forma Therapeutics for $1.1 billion in 2022, when the drug was in ...

Roche could be just months away from an FDA approval of Gazyva as the first anti-CD20 therapy for systemic lupus ...

Jazz Pharma's Ziihera and Eli Lilly's Jaypirca, respectively – have been recommended by reimbursement agency NICE for NHS use ...